ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Northwestern, Rochester, Howard First In Line For Limited Construction Funds

August 20, 1976

Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February

October 21, 1977

Clinton Budget Proposes Increase For AIDS, tuberculosis, In FY94

April 23, 1993

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008